Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00145613 2009-02-13

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Phase 2 Completed

25 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00143559 2009-01-29

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Phase 2 Completed

17 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00152139 2009-01-29

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

33 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00186823 2009-01-29

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

57 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

PembroRad

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Stem Cell Transplantation for Patients With Hematologic Malignancies

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies